Amcinonide

Amcinonide is a corticosteroid (a class of steroid hormones formed in the cortex of the adrenal gland and having antiinflammatory properties). Amcinonide is used to treat swelling, inflammation, or itching of skin conditions such as eczema, dermatitis, rashes, insect bites, allergies and other irritations.

Brands
CYCLOCORT AMCINIDE AMCIN
Adult Dose
Neonatal
Paedriatic
Characteristics
Amcinonide also known as Amanoxidum, Amanoxidum, Amanoxidum. . It is of Synthetic origin and belongs to sternids. . The Molecular Weight of Amcinonide is 502.60.
Contraindications
Amcinonide is contraindicated in conditions like Allergy,Bacterial infections,Fungal infection,Skin TB,Hypersensitivity to the drug.
Effects
The signs and symptoms that are produced after the acute overdosage of Amcinonide include Menstrual problem, thinning of skin, Impotence, Bruising, Facial hair.The symptomatic adverse reactions produced by Amcinonide are more or less tolerable and if they become severe, they can be treated symptomatically, these include Irritation, Itching, Burning, Allergic contact dermatitis, Folliculitis, Striae, Perioral dermatitis, Maceration of the skin, Hypopigmentation, Skin atrophy, Dryness, Skin thinning, Superinfection or oppurtunistic infections, Skin Atrophy, acneiform eruptions, hypopigmentation.
Indications
Amcinonide is primarily indicated in conditions like Dermatosis, Skin diseases.
Interactions
No data regarding the interactions of Amcinonide was found.
Interfrence
Risks
Drug should not be given to Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Lotion, Oint, Cream Store in a well closed container, Below 40°C. Do not Freeze. Protect from Sunlight.
Warnings
Do not use amcinonide if there is infection or sores present on the area to be treated. Do not use this medication near the eyes (if have glaucoma). This medication should be used cautiously during pregnancy or lactation, only if clearly needed.Patients receiving a large of potent topical steroid applied to a large surface area under an occulusive dressing should be evaluted periodically for evidence of hypothalamic pituitary adrenal CHPA axis suppression by using urinary free cortisol and ACTH stimulation test.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.